{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:14:01Z","timestamp":1786997641580,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.transproceed.2020.01.054","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T19:10:36Z","timestamp":1584126636000},"page":"1005-1009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Low-dose Thymoglobulin vs Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: A Prospective Randomized Trial"],"prefix":"10.1016","volume":"53","author":[{"given":"Gustavo","family":"Martinez-Mier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro I.","family":"Moreno-Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Budar-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco T.","family":"M\u00e9ndez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Allende-Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Jim\u00e9nez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Barrera-Amoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Aguilar-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza","family":"De la Paz-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Soto-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamilli","family":"Rivera-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Mart\u00ednez-Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.transproceed.2020.01.054_bib1","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.01.054_bib2","doi-asserted-by":"crossref","first-page":"E450","DOI":"10.1111\/ctr.12021","article-title":"The role of thymoglobulin induction in kidney transplantation: an update","volume":"26","author":"Mourad","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2020.01.054_bib3","first-page":"CD00389","article-title":"Interleukin 2 receptor antagonists for kidney transplant recipients","volume":"1","author":"Webster","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transproceed.2020.01.054_bib4","series-title":"Thymoglobulin\u00ae [package insert on the internet]","year":"2017"},{"key":"10.1016\/j.transproceed.2020.01.054_bib5","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2020.01.054_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e31825a7d1f","article-title":"Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry","volume":"94","author":"Gaber","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.054_bib7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/phar.1624","article-title":"Evaluation of a weight-based rabbit antithymocyte globulin induction dosing regimen for kidney transplant recipients","volume":"35","author":"Pennington","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.transproceed.2020.01.054_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/TP.0b013e3181b6f38c","article-title":"Reduced rabbit antithymocyte globulin induction for prevention of acute rejection in high-risk patients","volume":"88","author":"Klem","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.054_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00007890-200202150-00025","article-title":"Short course induction immunosuppression with thymoglobulin for renal transplant recipients","volume":"73","author":"Agha","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.054_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12977","article-title":"The appropriate dose of thymoglobulin induction therapy in kidney transplantation","volume":"31","author":"Nafar","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2020.01.054_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.trim.2012.02.003","article-title":"The effect of low and ultra-low dosages of thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients","volume":"262","author":"Kho","year":"2012","journal-title":"Transplant Immunol"},{"key":"10.1016\/j.transproceed.2020.01.054_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1432-2277.2006.00270.x","article-title":"Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation","volume":"19","author":"Wong","year":"2006","journal-title":"Transplant Int"},{"key":"10.1016\/j.transproceed.2020.01.054_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.transproceed.2011.01.034","article-title":"Low-dose rabbit antithymocyte globulin induction therapy results in prolonged selective lymphocyte depletion irrespective of maintenance immunosuppression","volume":"43","author":"Pankewycz","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2020.01.054_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.transproceed.2011.01.035","article-title":"Low-dose rabbit antithymocyte globulin versus basiliximab in low risk renal transplant recipients: 8 year follow-up","volume":"43","author":"Laftavi","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2020.01.054_bib15","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.transproceed.2018.02.088","article-title":"Thymoglobulin vs basiliximab induction therapy in low-risk kidney transplant recipients: a single center experience","volume":"50","author":"Lee","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2020.01.054_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The Banff 2015 Kidney Meeting Report: current challenges in rejection classification and prospects for adopting molecular pathology","volume":"17","author":"Loupy","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.01.054_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A\u00a0more accurate method to estimate glomerular filtration rate from serum creatinine","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2020.01.054_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0000000000000469","article-title":"Peak panel reactive antibody, cancer, graft, and patient outcomes in kidney transplant recipients","volume":"99","author":"Lim","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.054_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/tan.12147","article-title":"Ceppellini Lecture 2012: collateral damage from HLA mismatching in kidney transplantation","volume":"82","author":"Opelz","year":"2013","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.transproceed.2020.01.054_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ndt\/gfh541","article-title":"Duration of end-stage renal disease and kidney transplant outcome","volume":"20","author":"Goldfarb-Rumyantzev","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2020.01.054_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.transproceed.2017.03.064","article-title":"Influence of long-term dialysis on the outcome of kidney transplantation: a single-center study","volume":"49","author":"Masaki","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2020.01.054_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.transproceed.2014.11.018","article-title":"Safety and efficacy of induction treatment with low thymoglobulin doses in kidney transplantation from expanded criteria donors","volume":"47","author":"Sancho Calabuig","year":"2015","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519316872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519316872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:36:54Z","timestamp":1758577014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519316872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0041134519316872"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.054","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose Thymoglobulin vs Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: A Prospective Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}